Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.71%50.51B | 0.06%236.54B | -2.46%52.45B | 5.76%236.39B | 0.21%49.08B | 1.82%56.81B | 9.16%76.72B | 10.99%53.78B | 26.83%223.52B | 10.96%48.98B |
| Cost of revenue | -6.51%51.57B | -1.59%229.22B | -6.80%55.16B | -14.35%232.91B | -16.96%52.19B | -19.01%54.93B | -20.18%66.61B | 2.39%59.18B | 56.80%271.92B | 35.90%62.84B |
| Gross profit | 60.84%-1.06B | 110.34%7.32B | 49.97%-2.7B | 107.19%3.48B | 77.60%-3.1B | 115.64%1.88B | 176.77%10.11B | 42.19%-5.41B | -1,822.67%-48.41B | -560.00%-13.86B |
| Operating expense | ||||||||||
| Operating profit | 60.84%-1.06B | 110.34%7.32B | 49.97%-2.7B | 107.19%3.48B | 77.60%-3.1B | 115.64%1.88B | 176.77%10.11B | 42.19%-5.41B | -1,822.67%-48.41B | -560.00%-13.86B |
| Net non-operating interest income (expenses) | -34.23%-600M | -15.79%-1.92B | -7.97%-447M | -47.86%-1.66B | -1.49%-408M | -49.46%-414M | -94.04%-423M | -84.00%-414M | -12.99%-1.12B | -79.46%-402M |
| Non-operating interest income | 0.00%1M | 400.00%5M | 0.00%1M | 0.00%1M | --0 | --1M | -200.00%-1M | --1M | -50.00%1M | --0 |
| Non-operating interest expense | 34.15%601M | 16.02%1.93B | 7.95%448M | 47.82%1.66B | 1.49%408M | 49.82%415M | 92.69%422M | 84.44%415M | 18.09%1.12B | 79.46%402M |
| Net investment income | 21.71%157M | 21.78%246M | 24.04%129M | -5.16%202M | 1M | -5.38%88M | 0.00%9M | -6.31%104M | 5.97%213M | 0 |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 55.26%59M | -7.88%222M | -38.71%38M | -31.73%241M | -33.33%58M | -34.38%63M | -34.09%58M | -24.39%62M | 9.97%353M | 102.33%87M |
| Special income (charges) | -82.99%67M | -24.72%67M | 33.56%394M | 68.94%223M | 86.84%71M | -90.91%11M | 2,125.00%89M | 29.96%295M | 132M | |
| Less:Other special charges | ---- | 11.93%-347M | 24.72%-67M | -33.56%-394M | -68.94%-223M | -86.84%-71M | 90.91%-11M | -2,125.00%-89M | -29.96%-295M | ---132M |
| Less:Write off | ---- | --280M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 2,166.67%136M | -190.43%-273M | -82.86%6M | 29.85%-94M | 29.11%-56M | 59.06%-52M | -151.22%-21M | 12.90%35M | -189.33%-134M | 30.70%-79M |
| Income before tax | 55.09%-1.31B | 120.60%5.67B | 47.40%-2.91B | 105.26%2.57B | 76.74%-3.28B | 113.40%1.64B | 174.22%9.74B | 40.84%-5.53B | -1,896.06%-48.8B | -551.94%-14.12B |
| Income tax | 300.00%124M | 4,588.00%1.17B | -80.75%31M | 100.72%25M | -157.69%-1.22B | 228.26%302M | 123.96%778M | 106.59%161M | -695.39%-3.49B | 501.52%2.11B |
| Net income | 51.36%-1.43B | 76.75%4.49B | 48.33%-2.94B | 105.61%2.54B | 87.25%-2.07B | 110.85%1.33B | 190.74%8.97B | 17.56%-5.69B | -2,226.18%-45.31B | -888.91%-16.23B |
| Net income continuous operations | 51.34%-1.43B | 76.68%4.49B | 48.34%-2.94B | 105.61%2.54B | 87.26%-2.07B | 110.85%1.33B | 190.73%8.97B | 17.57%-5.69B | -2,226.23%-45.31B | -888.97%-16.23B |
| Noncontrolling interests | 400.00%10M | 12.58%170M | -81.82%2M | 2.72%151M | 36.36%105M | -80.00%7M | -24.32%28M | 650.00%11M | -14.53%147M | -23.00%77M |
| Net income attributable to the company | 51.04%-1.44B | 80.76%4.32B | 48.38%-2.94B | 105.26%2.39B | 86.67%-2.17B | 110.75%1.33B | 190.11%8.94B | 17.36%-5.7B | -2,420.42%-45.46B | -836.59%-16.31B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 51.04%-1.44B | 80.76%4.32B | 48.38%-2.94B | 105.26%2.39B | 86.67%-2.17B | 110.75%1.33B | 190.11%8.94B | 17.36%-5.7B | -2,420.42%-45.46B | -836.59%-16.31B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 51.02%-26.54 | 80.80%79.59 | 48.38%-54.19 | 105.26%44.02 | 86.67%-40.03 | 110.76%24.43 | 190.11%164.6 | 17.36%-104.98 | -2,421.72%-836.98 | -837.66%-300.24 |
| Diluted earnings per share | 51.02%-26.54 | 80.80%79.59 | 48.38%-54.19 | 105.26%44.02 | 86.67%-40.03 | 110.75%24.4145 | 190.11%164.5888 | 17.36%-104.98 | -2,421.72%-836.98 | -836.62%-300.24 |
| Dividend per share | 0 | 100.00%20 | 0 | 10 | 5 | 0 | 5 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |